Incidence of Complete Remission in 221 PML-RARα–positive INT 0129 Patients as a Function of Protocol Induction Therapy and PML-RARα mRNA Type
| PML-RARα mRNA type . | Protocol Induction Therapy . | ||
|---|---|---|---|
| . | Either3-150 . | Chemotherapy . | ATRA . |
| S-form | 65/82 (79) | 34/44 (77) | 31/38 (82) |
| L-form | 84/121 (69) | 40/61 (66) | 44/60 (73) |
| V-form | 12/18 (67) | 6/10 (60) | 6/8 (75) |
| Totals | 161/221 (73) | 80/115 (69) | 81/106 (76) |
| PML-RARα mRNA type . | Protocol Induction Therapy . | ||
|---|---|---|---|
| . | Either3-150 . | Chemotherapy . | ATRA . |
| S-form | 65/82 (79) | 34/44 (77) | 31/38 (82) |
| L-form | 84/121 (69) | 40/61 (66) | 44/60 (73) |
| V-form | 12/18 (67) | 6/10 (60) | 6/8 (75) |
| Totals | 161/221 (73) | 80/115 (69) | 81/106 (76) |
P = .14, S-form v L-form cases.